Le Lézard
Classified in: Health
Subject: AWD

SightMD Physicians Recognized as 2024 Super Doctors® and Rising Stars


SightMD, a leading multi-specialty ophthalmology practice in New York, is proud to announce that several of its esteemed physicians have been recognized as 2024 Super Doctors® and Rising Stars. These prestigious accolades highlight the exceptional medical expertise, dedication to patient care, and outstanding contributions to the field of ophthalmology exhibited by these individuals.

HAUPPAUGE, N.Y. , May 20, 2024 /PRNewswire-PRWeb/ -- SightMD, a leading multi-specialty ophthalmology practice in New York, is proud to announce that several of its esteemed physicians have been recognized as 2024 Super Doctors® and Rising Stars. These prestigious accolades highlight the exceptional medical expertise, dedication to patient care, and outstanding contributions to the field of ophthalmology exhibited by these individuals.

Dr. David Immanuel said "I am deeply grateful for being recognized as a Super Doctor. It is truly humbling to be acknowledged for the work we do every day to improve the vision and lives of our patients."

The Super Doctors® and Rising Stars awards are prestigious acknowledgments in the medical community, and MSP Communications is renowned for its rigorous selection process, which involves peer nominations, independent research, and professional achievement assessments. Each year, MSP Communications undertakes a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties As part of this evaluation, physicians are asked to consider the following question: "If you needed medical care in one of the following practice areas, which doctor would you choose?"
The Super Doctors® designation is a testament to the exemplary skills and commitment demonstrated by the following SightMD physicians:

Dr. Samuel Baharestani
Dr. Jonathan Ellant
Dr. James Gordon
Dr. David Immanuel
Dr. Brad Kligman
Dr. Faye Knoll
Dr. Michelle Liebert
Dr. Jeff Martin
Dr. Norman Saffra

In addition to Super Doctors®, SightMD is pleased to acknowledge it's Rising Stars, a group of promising and talented physicians who have shown exceptional promise early in their careers:

Dr. Gaurav Chandra
Dr. Mukesh Kumar
Dr. Amy Mehta
Dr. Alanna Nattis
Dr. Leon Rafailov
Dr. Eric Rosenberg
Dr. Sabah Shah

Jonathan Lujan, CEO at Sight Growth Partners expressed his pride in the physicians, stating, "We are thrilled to see these physicians at SightMD recognized for their outstanding contributions to the field of ophthalmology. Their dedication to excellence and commitment to patient care exemplify the core values of SightMD."

Here are some words from the honored physicians:

Dr. Samuel Baharestani: "Receiving the Super Doctors® designation is a tremendous honor and a testament to the dedication of our entire team at SightMD. We are committed to providing the highest quality care to our patients."

Dr. David Immanuel: "I am deeply grateful for being recognized as a Super Doctor. It is truly humbling to be acknowledged for the work we do every day to improve the vision and lives of our patients."

Dr. Michelle Liebert: "Being named a Super Doctor is a reflection of the collaborative efforts of our entire staff at SightMD. I am proud to be part of such a dedicated team."

Dr. Mukesh Kumar: "As a Rising Star, I am honored to be among such esteemed colleagues. This recognition inspires me to continue striving for excellence in patient care and professional growth."

Dr. Leon Rafailov: "I am grateful for the opportunity to contribute to the field of Ophthalmic Plastic Surgery as a Rising Star. This recognition motivates me to further advance my skills and knowledge for the benefit of our patients."

These accolades highlight SightMD's commitment to delivering exceptional eye care services and its dedication to excellence in the field of ophthalmology. SightMD ophthalmologists recognized this year span the full range of care offered to the patients within the practice. Individuals on the list include professionals from the Cataract and Comprehensive Eye Care, Ophthalmic Plastic Surgery, Medical & Surgical Disease of the Retina, Pediatric Ophthalmology, Glaucoma, Cornea, Neuro-Ophthalmology services. SightMD extends its heartfelt congratulations to all the recognized physicians for their well-deserved honors. The organization remains dedicated to advancing eye care and maintaining the highest standards of excellence in the field.

About SightMD
SightMD is a rapidly-growing integrated ophthalmic group, offering patients access to over 80 doctors through the convenience of 40 locations across New York. SightMD's track record of providing clinically-excellent care spans over 50 years, and its services include general eye exams, laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. Sight Growth Partners is the administrative services provider for SightMD as well as SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. For more information about SightMD, please visit sightmd.com

About Sight Growth Partners
Sight Growth Partners is the leading administrative services provider for the ophthalmology sector including SightMD in New York, SightMD Connecticut, SightMD New Jersey, and SightMD Pennsylvania. It has over 140 employees who provide administrative solutions to physicians, ophthalmology clinics and ambulatory surgery centers. Sight Growth Partners provides its clients with world-class administrative services, including a 24/7 call center, billing, credentialing, marketing, human resources, and other services, enabling them to continue delivering best-in-class care to patients in their communities. Sight Growth Partners is backed by Chicago Pacific Founders, a leading middle market private equity firm which focuses exclusively on partnerships with growing companies in the healthcare services sector. For more information about Sight Growth Partners, please visit http://www.sightgrowthpartners.com.

Media Contact

Stephanie Penza, SightGrowthPartners, 6318352613, [email protected], www.sightmd.com

Facebook LinkedIn

SOURCE SightGrowthPartners


These press releases may also interest you

at 18:05
A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, London, used an ultra-sensitive liquid biopsy to...

at 17:35
Genmab A/S today announced new efficacy and safety data from two ongoing Phase 1/2 clinical trials evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, in adult patients with certain types of follicular lymphoma...

at 14:35
Positive results from the LAURA Phase III trial showed AstraZeneca's TAGRISSO® (osimertinib) demonstrated a statistically significant and highly clinically meaningful improvement in progression-free survival (PFS) for patients with unresectable,...

at 12:35
CatalYm today announced positive new follow-up results from its ongoing "GDFATHER" Phase 1/2a trial (GDF-15 Antibody-mediaTed Human Effector Cell Relocation Phase 1/2a) (NCT04725474) in an oral presentation at the American Society of Clinical...

at 11:35
In an era where healthcare innovation is paramount, KFSHRC Jeddah has made headway in the treatment of severe Xanthoma through the deployment of a modified plasma exchange protocol. This milestone underscores KFSHRC's position as a trailblazer in...

at 11:00
GSK plc (LSE/NYSE: GSK) today announced positive results from an interim analysis of the DREAMM-8 phase III head-to-head trial evaluating belantamab mafodotin, in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care,...



News published on and distributed by: